Endo Sets Aside $775 Million to Settle Remaining Mesh Lawsuits
Endo International Plc said it agreed to set aside $775 million to resolve the last batch of lawsuits alleging the company’s vaginal-mesh implants eroded in some women, leaving them incontinent and in pain.
Endo’s settlement of the remaining 22,000 mesh suits means the company has now set aside more than $2.6 billion to wipe out cases over the flawed medical devices, according to filings with the U.S. Securities and Exchange Commission.
The accord comes a year after Dublin-based Endo shut down one of its units that makes mesh implants, used to support internal organs or treat incontinence, after being hit with numerous complaints over the devices.
Read the full article here.